Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have been given a consensus recommendation of “Moderate Buy” by the twelve ratings firms that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $10.50.

Several brokerages recently weighed in on AVAH. Barclays cut their price target on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday, May 18th. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. Truist Financial raised their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. Weiss Ratings lowered shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Finally, BMO Capital Markets reduced their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th.

Insider Activity

In other news, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60. Following the sale, the insider owned 13,450,547 shares of the company’s stock, valued at $83,931,413.28. This trade represents a 30.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Patrick A. Cunningham sold 125,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total transaction of $948,750.00. Following the sale, the insider directly owned 212,755 shares in the company, valued at $1,614,810.45. The trade was a 37.01% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 19,967,240 shares of company stock worth $124,764,328 over the last 90 days. Company insiders own 5.30% of the company’s stock.

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in AVAH. Dynamic Technology Lab Private Ltd grew its stake in Aveanna Healthcare by 8.9% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after acquiring an additional 1,151 shares during the period. Barclays PLC grew its stake in Aveanna Healthcare by 0.8% in the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after acquiring an additional 1,366 shares during the period. Franklin Resources Inc. grew its stake in Aveanna Healthcare by 4.5% in the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock valued at $316,000 after acquiring an additional 1,528 shares during the period. Intech Investment Management LLC grew its stake in Aveanna Healthcare by 9.8% in the 4th quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock valued at $159,000 after acquiring an additional 1,739 shares during the period. Finally, Balboa Wealth Partners grew its stake in Aveanna Healthcare by 13.5% in the 4th quarter. Balboa Wealth Partners now owns 16,890 shares of the company’s stock valued at $138,000 after acquiring an additional 2,007 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

Aveanna Healthcare Stock Performance

Shares of Aveanna Healthcare stock opened at $7.52 on Wednesday. The firm has a market capitalization of $1.64 billion, a P/E ratio of 6.37, a PEG ratio of 0.75 and a beta of 1.93. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The company has a 50 day moving average price of $6.88 and a 200 day moving average price of $7.63. Aveanna Healthcare has a 52 week low of $3.73 and a 52 week high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.13 by $0.05. The firm had revenue of $647.92 million during the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. Aveanna Healthcare’s revenue was up 15.9% compared to the same quarter last year. Sell-side analysts expect that Aveanna Healthcare will post 0.65 EPS for the current year.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.